Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rocket Pharmaceuticals
Biotech
Rocket gene therapy's flight to approval delayed by FDA
Rocket Pharmaceuticals’ flight to approval for Kresladi has been delayed after the FDA issued a CRL requesting additional manufacturing information.
James Waldron
Jun 28, 2024 9:58am
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Mar 29, 2024 9:30am
Rocket boosted by FDA alignment on pivotal gene therapy trial
Sep 13, 2023 9:21am
ASGCT 2023: New preclinical updates from Tessera, Tune and more
May 23, 2023 10:00am
Rocket's hematology programs blast off toward regulators
May 19, 2023 11:01am
Rocket receives show of confidence in gene therapy from FDA
Feb 7, 2023 10:25am